Mitochondrial fission factor promotes cisplatin resistancein hepatocellular carcinoma: Mff promotes cisplatin resistance in HCC

Hepatocellular carcinoma (HCC) is the most common primary liver tumor and one of the leading causes of cancer-related death worldwide. Chemotherapeutic agents/regimens such as cisplatin (DDP) are frequently used for advanced HCC treatment. However, drug resistance remains a major hindrance and the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoliang, Wu, Quanlin, Ma, Fujun, Zhang, Xinxin, Cai, Lei, Yang, Xuekang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828151/
https://www.ncbi.nlm.nih.gov/pubmed/35538029
http://dx.doi.org/10.3724/abbs.2022007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828151/
https://www.ncbi.nlm.nih.gov/pubmed/35538029
http://dx.doi.org/10.3724/abbs.2022007

Ejemplares similares